Verano Holdings (VRNO) Total Liabilities (2021 - 2026)
Verano Holdings' (VRNO) quarterly Total Liabilities came in at $1.0 billion in Q1 2026, down 0.55% year-on-year from $1.0 billion in Q1 2025, and down 1.68% on a QoQ basis from $1.0 billion in Q4 2025.
Verano Holdings (VRNO) Total Liabilities (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Total Liabilities data on file, last reported at $1.0 billion in Q1 2026.
- On a quarterly basis, Total Liabilities fell 0.55% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 0.55% decrease from a year earlier, with the FY2025 full-year figure at $1.0 billion, changed 0.39% from the prior year.
- Total Liabilities for Q1 2026 stood at $1.0 billion, down from $1.0 billion in the prior quarter.
- Over the last five years, Total Liabilities for VRNO reached as high as $1.1 billion in Q3 2024 and fell as low as $1.0 billion in Q2 2025.
- Historically, Total Liabilities has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
- Across the five-year window, Total Liabilities advanced 5.31% in 2024 and fell 5.08% in 2025, its largest moves.
- Year by year, Total Liabilities stood at $1.1 billion in 2022, then advanced by 2.29% to $1.1 billion in 2023, then declined by 3.28% to $1.0 billion in 2024, then decreased by 0.39% to $1.0 billion in 2025, then declined by 1.68% to $1.0 billion in 2026.
- Per Business Quant data, the three most recent Total Liabilities figures were $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 1.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Bn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 1.03 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 1.10 Bn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 1.08 Bn |
| Dec 31, 2023 | 1.08 Bn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 1.03 Bn |
| Dec 31, 2022 | 1.05 Bn |
| Sep 30, 2022 | 1.08 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Dec 31, 2021 | 1.07 Bn |